New histopathological terminology for well-differentiated hepatocellular lesions in unusual clinico-pathological scenarios: HCA-like and FNH-like
Open Access
- 6 February 2026
- journal article
- review article
- Published by Elsevier in JHEP Reports
- Vol. 8 (5) , 101778
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Clinical relevance of subtyping CTNNB1‐mutated hepatocellular adenomas: Different risk patterns according to the mutation typeLiver International Communications, 2024
- ASS1 Overexpression: A Hallmark of Sonic Hedgehog Hepatocellular Adenomas; Recommendations for Clinical PracticeHepatology Communications, 2020
- Hepatocellular nodules in vascular liver diseasesVirchows Archiv, 2018
- Benign and malignant hepatocellular lesions in patients with vascular liver diseasesAbdominal Radiology, 2018
- Argininosuccinate synthase 1 (ASS1): A marker of unclassified hepatocellular adenoma and high bleeding riskHepatology, 2017
- Hepatocellular adenoma with malignant transformation in a patient with neonatal portal vein thrombosisHepatology, 2016
- Genotype‐phenotype correlation of CTNNB1 mutations reveals different ß‐catenin activity associated with liver tumor progressionHepatology, 2016
- Well-differentiated hepatocellular neoplasm of uncertain malignant potential: proposal for a new diagnostic categoryHuman Pathology, 2014
- Hepatocellular adenoma management and phenotypic classificationHepatology, 2009
- Terminology of nodular hepatocellular lesionsHepatology, 1995